Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2024-12-09 13:41:37]
5 Years H Index
5
Impact Factor (IF)
0.08
5 Years IF
0.07
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2017 0 0.54 0.13 0 31 31 38 4 4 0 0 3 75 4 0.13 0.22
2018 0.13 0.55 0.11 0.13 43 74 47 8 12 31 4 31 4 1 12.5 4 0.09 0.23
2019 0.2 0.57 0.14 0.2 68 142 34 20 32 74 15 74 15 6 30 4 0.06 0.23
2020 0.15 0.68 0.13 0.15 68 210 26 27 59 111 17 142 21 1 3.7 2 0.03 0.32
2021 0.13 0.8 0.11 0.13 69 279 19 31 90 136 17 210 28 1 3.2 3 0.04 0.29
2022 0.09 0.84 0.12 0.12 77 356 7 41 131 137 13 279 33 1 2.4 2 0.03 0.25
2023 0.08 0.86 0.08 0.07 62 418 0 33 164 146 11 325 24 3 9.1 0 0.25
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12018Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review. (2018). Afiqah, Nik Annie ; Timilsina, Sabina ; Kaphle, Dinesh ; Regmi, Kabindra. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0025-4.

Full description at Econpapers || Download paper

9
22018Cost Analysis of a Digital Health Care Model in Sweden. (2018). Ekman, Bjorn. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0059-7.

Full description at Econpapers || Download paper

6
32017Health System Efficiency: A Fragmented Picture Based on OECD Data. (2017). Theune, Katja ; Behr, Andreas. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0010-y.

Full description at Econpapers || Download paper

6
42017Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Paterson, Kenneth R ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1.

Full description at Econpapers || Download paper

6
52017Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations. (2017). Baio, Gianluca ; Mason, Alexina J ; Gabrio, Andrea. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0029-0.

Full description at Econpapers || Download paper

6
62018Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward. (2018). Swaminathan, Soumya ; Gauba, Vijay K ; Downey, Laura E ; Prinja, Shankar. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0037-0.

Full description at Econpapers || Download paper

5
72019Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. (2019). Zimmermann, Nina ; Schneider, Peter ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-019-0120-9.

Full description at Econpapers || Download paper

5
82017Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Hawton, Annie ; Round, Jeff. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2.

Full description at Econpapers || Download paper

5
92018Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends. (2018). Holm-Larsen, Tove ; Traulsen, Janine Marie ; Piatkiewicz, Trevor Jozef. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0044-1.

Full description at Econpapers || Download paper

5
102020How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton. (2020). Roope, Laurence ; Becker, Frauke ; Buckell, John ; Clarke, Philip M ; Duch, Raymond ; Barnett, Adrian ; Sindelar, Jody L ; Violato, Mara ; Candio, Paolo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00228-5.

Full description at Econpapers || Download paper

5
112017Model Registration: A Call to Action. (2017). Sampson, Christopher ; Wrightson, Tim . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0019-2.

Full description at Econpapers || Download paper

4
122020Group Testing for SARS-CoV-2: Forward to the Past?. (2020). Roope, Laurence ; Barnett, Adrian ; Pouwels, Koen B ; Clarke, Philip M ; Nolan, Terry M ; Hunter, David J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-020-00217-8.

Full description at Econpapers || Download paper

4
132019National Health Insurance Databases in Indonesia, Vietnam and the Philippines. (2019). Duc, Duong Tuan ; Hendrawan, Donni ; Ramadani, Royasia Viki ; Yi, Junice ; Tuan, Pham Huy. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0127-2.

Full description at Econpapers || Download paper

4
142020Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights. (2020). Flessa, Steffen ; Ben-Debba, Lilia ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0141-4.

Full description at Econpapers || Download paper

3
152018Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India. (2018). Kaur, Manmeet ; Duseja, Ajay ; Bahuguna, Pankaj ; Prinja, Shankar ; Chawla, Yogesh Kumar. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0041-4.

Full description at Econpapers || Download paper

3
162021The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach. (2021). Martinez, Omar ; Kakolyris, Andreas ; Brennan-Ing, Mark ; Delacruz, Juan J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00238-3.

Full description at Econpapers || Download paper

3
172017Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations. (2017). Baio, Gianluca ; Mason, Alexina J ; Gabrio, Andrea. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0015-6.

Full description at Econpapers || Download paper

3
182018Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis. (2018). Bureau, Isabelle ; Dallongeville, Jean ; Simon, Dominique ; Charbonnel, Bernard ; Detournay, Bruno ; Gourmelen, Julie ; Levy-Bachelot, Laurie ; Dejager, Sylvie. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0050-3.

Full description at Econpapers || Download paper

3
192019Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017. (2019). Barry, Michael ; Tilson, Lesley ; McCullagh, Laura ; Usher, Cara . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0136-1.

Full description at Econpapers || Download paper

2
202021Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. (2021). Jacob, Ian ; Jones, Beverley ; Stainthorpe, Angela ; Gordon, Jason ; Borrill, John ; Yuan, Yong ; Diaz, Jose ; Hertel, Nadine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:4:d:10.1007_s41669-021-00279-2.

Full description at Econpapers || Download paper

2
212018An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery. (2018). Campbell, Julie ; Neil, Amanda ; Hensher, Martin ; Palmer, Andrew J ; Wilkinson, Stephen ; Otahal, Petr ; Venn, Alison. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-017-0060-1.

Full description at Econpapers || Download paper

2
222020Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. (2020). Bousmah, Marwân-al-Qays ; Delaporte, E ; Sagaon-Teyssier, L ; Spire, B ; Nishimwe, M L ; Ciaffi, L ; Boyer, S ; Kouanfack, C ; Sawadogo, A ; Ngom, N F ; Mpoudi-Etame, M P ; Toby, R ; M.-Q. Bousmah, ; Koulla-Shiro, S ; March, L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0157-9.

Full description at Econpapers || Download Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00345-3.

Full description at Econpapers || Download paper

2
242020Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis. (2020). Al-Jedai, Ahmed ; Maraiki, Fatma ; de Vol, Edward B ; Bazarbashi, Shouki ; Iskedjian, Michael ; Aljuffali, Ibrahim A ; Alhammad, Ali M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00211-0.

Full description at Econpapers || Download paper

2
252020Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers. (2020). Wirtz, Heidi S ; Bychenkova, Anna ; di Tanna, Gian Luca ; Globe, Gary ; Burrows, Karen L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-019-00173-y.

Full description at Econpapers || Download paper

2
262017Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications. (2017). Godman, Brian B ; Falleiros, Daniel Resende ; Ezenduka, Charles C. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0021-8.

Full description at Econpapers || Download paper

2
27An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patients’ Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners. (2018). Campbell, Julie ; Venn, Alison ; Neil, Amanda ; Hensher, Martin ; Palmer, Andrew J ; Wilkinson, Stephen. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0038-z.

Full description at Econpapers || Download paper

2
282018Hospital Pharmacists in Europe: Between Warehouse and Prescription Pad?. (2018). Padula, Anna ; Garattini, Livio. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-018-0069-0.

Full description at Econpapers || Download paper

2
292021National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison. (2021). Prinja, Shankar ; Downey, Laura E ; Aggarwal, Arun Kumar ; Sharma, Deepshikha. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00250-7.

Full description at Econpapers || Download paper

2
302017Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity. (2017). Niakas, D ; Spanou, A ; Aletras, V ; Mavrodi, A. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0033-4.

Full description at Econpapers || Download paper

2
312021Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis. (2021). Goodall, Stephen ; Cook, Greg ; Kim, Hansoo ; Liew, Danny. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-021-00265-8.

Full description at Econpapers || Download paper

2
322019Value Assessment Frameworks in the United States: A Call for Patient Engagement. (2019). Montero, Alberto J ; Ali, Askal A ; Diaby, Vakaramoko. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:1:d:10.1007_s41669-018-0094-z.

Full description at Econpapers || Download paper

2
332020Authors’ Reply to Salamanca: “Systematic Review of Economic Evaluations in Primary Open Angle Glaucoma: Decision Analytic Modeling Insights”. (2020). Flessa, Steffen ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-020-00223-w.

Full description at Econpapers || Download paper

2
342019Long-Term Inpatient Hospital Utilisation and Costs (2007–2008 to 2015–2016) for Publicly Waitlisted Bariatric Surgery Patients in an Australian Public Hospital System Based on Australia’s Activity-Bas. (2019). Campbell, Julie ; Davies, Daniel ; Hensher, Martin ; Palmer, Andrew J ; Wilkinson, Stephen ; Neil, Amanda ; Kuzminov, Alexandr ; Venn, Alison ; Jordan, Ian ; Hagan, Barry ; Green, Matthew. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0140-5.

Full description at Econpapers || Download Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications. (2018). Haycox, Alan ; Martin, Antony ; Godman, Brian ; Jakupi, Arianit ; Baholli, Indrit. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-017-0066-8.

Full description at Econpapers || Download paper

2
362020Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic. (2020). Hatswell, Anthony J. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-020-00216-9.

Full description at Econpapers || Download paper

2
372021Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study. (2021). Li, Hong-Chao ; He, Xiao-Ning ; Jiang, Shan ; Yang, Fan ; Wu, Jing ; Zhang, Tian-Tian. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:1:d:10.1007_s41669-020-00212-z.

Full description at Econpapers || Download paper

2
382019Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial. (2019). Fors, Andreas ; Olofsson, Elisabeth Hansson ; Bolin, Kristian ; Pirhonen, Laura ; Gyllensten, Hanna ; Swedberg, Karl ; Ekman, Inger. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0126-3.

Full description at Econpapers || Download paper

2
392018Using Cerebrospinal Fluid Biomarker Testing to Target Treatment to Patients with Mild Cognitive Impairment: A Cost-Effectiveness Analysis. (2018). Gaugler, Joseph E ; McCarten, Riley J ; Kane, Robert L ; Michaud, Tzeyu L ; Kuntz, Karen M ; Nyman, John A. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0054-z.

Full description at Econpapers || Download paper

2
402022Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00311-5.

Full description at Econpapers || Download paper

2
412019A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers. (2019). Mills, Fergal ; Xie, Feng ; Tarride, Jean-Eric ; Foroutan, Naghmeh ; Levine, Mitchell. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0139-y.

Full description at Econpapers || Download paper

2
422019Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials. (2019). Sapra, Sandhya ; Lipton, Richard B ; di Tanna, Gian Luca ; Porter, Joshua K ; Villa, Guillermo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-018-0105-0.

Full description at Econpapers || Download paper

2
432019Check Your Checklist: The Danger of Over- and Underestimating the Quality of Economic Evaluations. (2019). , Geert. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0118-3.

Full description at Econpapers || Download paper

2
442018Healthcare Resource Uses and Out-of-Pocket Expenses Associated with Pulmonary TB Treatment in Thailand. (2018). Xie, Feng ; Dushoff, Jonathan ; Loeb, Mark ; Tanvejsilp, Pimwara. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0053-0.

Full description at Econpapers || Download paper

1
452022Community Distribution of Naloxone: A Systematic Review of Economic Evaluations. (2022). Garasia, Sophiya ; Tetreault, Robin ; Kearon, Joanne ; Cherrier, Nelda ; Guindon, Emmanuel. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00309-z.

Full description at Econpapers || Download paper

1
462018Cost-Effectiveness of Aspirin Adherence for Secondary Prevention of Cardiovascular Events. (2018). Lieberthal, Robert ; Varga, Stefan ; Djatche, Laurence M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:4:d:10.1007_s41669-018-0075-2.

Full description at Econpapers || Download paper

1
472020Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention. (2020). Gonzalez-Juanatey, Jose Ramon ; Lopez-Sendon, Jose Luis ; Suarez, Carmen ; Oyaguez, Itziar ; Soto, Javier ; Polanco, Carlos ; Andres-Nogales, Fernando. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-019-00186-7.

Full description at Econpapers || Download paper

1
482017The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review. (2017). Barnabas, Ruanne ; Devine, Beth ; Dimitrov, Dobromir ; Adamson, Blythe . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:1:d:10.1007_s41669-016-0009-9.

Full description at Econpapers || Download paper

1
492019Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma. (2019). Amin, Amerah ; Willis, Anna ; Nathan, Paul ; Bullement, Ash ; Bharmal, Murtuza ; Pescott, Chris ; Hatswell, Anthony ; Stapelkamp, Ceilidh ; Lilley, Cameron. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-018-0115-y.

Full description at Econpapers || Download paper

1
502021An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation Study. (2021). , David ; David, ; Hobbins, Anna ; Doherty, Edel ; Oneill, Ciaran. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00244-5.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12018Cost Analysis of a Digital Health Care Model in Sweden. (2018). Ekman, Bjorn. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0059-7.

Full description at Econpapers || Download paper

6
22017Health System Efficiency: A Fragmented Picture Based on OECD Data. (2017). Theune, Katja ; Behr, Andreas. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0010-y.

Full description at Econpapers || Download paper

4
32017Can Price Transparency Contribute to More Affordable Patient Access to Medicines?. (2017). Paterson, Kenneth R ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:3:d:10.1007_s41669-017-0028-1.

Full description at Econpapers || Download paper

3
42020Systematic Review of Economic Evaluations in Primary Open-Angle Glaucoma: Decision Analytic Modeling Insights. (2020). Flessa, Steffen ; Ben-Debba, Lilia ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0141-4.

Full description at Econpapers || Download paper

3
52020How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton. (2020). Roope, Laurence ; Becker, Frauke ; Buckell, John ; Clarke, Philip M ; Duch, Raymond ; Barnett, Adrian ; Sindelar, Jody L ; Violato, Mara ; Candio, Paolo. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00228-5.

Full description at Econpapers || Download paper

3
62018Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic Review. (2018). Afiqah, Nik Annie ; Timilsina, Sabina ; Kaphle, Dinesh ; Regmi, Kabindra. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0025-4.

Full description at Econpapers || Download paper

3
72018Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends. (2018). Holm-Larsen, Tove ; Traulsen, Janine Marie ; Piatkiewicz, Trevor Jozef. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0044-1.

Full description at Econpapers || Download paper

3
82020Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis. (2020). Al-Jedai, Ahmed ; Maraiki, Fatma ; de Vol, Edward B ; Bazarbashi, Shouki ; Iskedjian, Michael ; Aljuffali, Ibrahim A ; Alhammad, Ali M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00211-0.

Full description at Econpapers || Download paper

2
92019Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. (2019). Zimmermann, Nina ; Schneider, Peter ; Vogler, Sabine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:3:d:10.1007_s41669-019-0120-9.

Full description at Econpapers || Download paper

2
102018Health Technology Assessment for Policy Making in India: Current Scenario and Way Forward. (2018). Swaminathan, Soumya ; Gauba, Vijay K ; Downey, Laura E ; Prinja, Shankar. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0037-0.

Full description at Econpapers || Download paper

2
112021National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison. (2021). Prinja, Shankar ; Downey, Laura E ; Aggarwal, Arun Kumar ; Sharma, Deepshikha. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-020-00250-7.

Full description at Econpapers || Download paper

2
122020Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers. (2020). Wirtz, Heidi S ; Bychenkova, Anna ; di Tanna, Gian Luca ; Globe, Gary ; Burrows, Karen L. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-019-00173-y.

Full description at Econpapers || Download paper

2
132019Analysis of Health Technology Assessments of Orphan Drugs in Ireland from 2012 to 2017. (2019). Barry, Michael ; Tilson, Lesley ; McCullagh, Laura ; Usher, Cara . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:4:d:10.1007_s41669-019-0136-1.

Full description at Econpapers || Download paper

2
142022Correction to: Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00345-3.

Full description at Econpapers || Download paper

2
152022Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries. (2022). Kanavos, Panos ; Visintin, Erica ; Fontrier, Anna-Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:3:d:10.1007_s41669-021-00311-5.

Full description at Econpapers || Download paper

2
162017Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations. (2017). Baio, Gianluca ; Mason, Alexina J ; Gabrio, Andrea. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0015-6.

Full description at Econpapers || Download paper

2
172021Comparison of EQ-5D-3L with QLU-C10D in Metastatic Melanoma Using Cost-Utility Analysis. (2021). Goodall, Stephen ; Cook, Greg ; Kim, Hansoo ; Liew, Danny. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:3:d:10.1007_s41669-021-00265-8.

Full description at Econpapers || Download paper

2
182020Authors’ Reply to Salamanca: “Systematic Review of Economic Evaluations in Primary Open Angle Glaucoma: Decision Analytic Modeling Insights”. (2020). Flessa, Steffen ; Bartelt-Hofer, Jose. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:3:d:10.1007_s41669-020-00223-w.

Full description at Econpapers || Download paper

2
192017Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations. (2017). Baio, Gianluca ; Mason, Alexina J ; Gabrio, Andrea. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:2:d:10.1007_s41669-017-0029-0.

Full description at Econpapers || Download paper

2
202017Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Hawton, Annie ; Round, Jeff. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2.

Full description at Econpapers || Download paper

2
212021Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making. (2021). Jacob, Ian ; Jones, Beverley ; Stainthorpe, Angela ; Gordon, Jason ; Borrill, John ; Yuan, Yong ; Diaz, Jose ; Hertel, Nadine. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:4:d:10.1007_s41669-021-00279-2.

Full description at Econpapers || Download paper

2
222021Do Rural Residents in China Understand EQ-5D-5L as Intended? Evidence From a Qualitative Study. (2021). Li, Hong-Chao ; He, Xiao-Ning ; Jiang, Shan ; Yang, Fan ; Wu, Jing ; Zhang, Tian-Tian. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:1:d:10.1007_s41669-020-00212-z.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 11
YearTitle
2023Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. (2023). Li, Sha ; Yang, Zhihao ; Jiang, Jie ; Mukuria, Clara ; Luo, Nan ; Hong, Yanming ; Weng, Guizhi. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:2:d:10.1007_s10198-022-01465-7.

Full description at Econpapers || Download paper

2023Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana. (2023). Enemark, Ulrika ; Lindholm, Joergen Anders ; Ofori, Alex Owusu ; Labi, Appiah-Korang ; Fenny, Ama Pokuaa ; Otieku, Evans. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:2:d:10.1007_s41669-022-00385-9.

Full description at Econpapers || Download paper

2023Predictors of service integration by community based providers in New York State offering maternal and infant services. (2023). Patel, Rupal ; Chesna, Sharon ; Huang, Debbie ; Spector, Anya Y ; Ross, Abigail M ; Rahman, Rahbel. In: Children and Youth Services Review. RePEc:eee:cysrev:v:153:y:2023:i:c:s0190740923003195.

Full description at Econpapers || Download paper

2023Use of Advanced Flexible Modeling Approaches for Survival Extrapolation from Early Follow-up Data in two Nivolumab Trials in Advanced NSCLC with Extended Follow-up. (2023). Vanderpuye-Orgle, J ; Briggs, A ; Chaudhary, M A ; Edmondson-Jones, M ; Baio, G ; MacKay, E ; Penrod, J R ; Sharpe, D J ; Yates, G ; Rafiq, S ; Johannesen, K ; Siddiqui, M K. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:1:p:91-109.

Full description at Econpapers || Download paper

2023Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial. (2023). P.-O. Thuresson, ; Launonen, Aino ; Felizzi, F. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:1:d:10.1007_s41669-022-00339-1.

Full description at Econpapers || Download paper

2023Value-Based Clinical Trials: Selecting Recruitment Rates and Trial Lengths in Different Regulatory Contexts. (2023). Forster, Martin ; Chick, Stephen E ; Alban, Andres. In: Management Science. RePEc:inm:ormnsc:v:69:y:2023:i:6:p:3516-3535.

Full description at Econpapers || Download paper

2023Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4.

Full description at Econpapers || Download paper

2023Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients. (2023). Wang, Pei ; Luo, Nan ; Zhao, Chun-Hua ; Zhu, Yan-Bo ; He, Jun-Yi ; Pan, Chen-Wei. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:6:d:10.1007_s10198-022-01523-0.

Full description at Econpapers || Download paper

2023How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe. (2023). Kamphuis, Bregtje W ; Fontrier, Anna-Maria ; Kanavos, Panos. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:120537.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023Systematic Review and Cost-Consequence Analysis of Ambu aScope 5 Broncho Compared with Reusable Flexible Bronchoscopes: Insights from Two US University Hospitals and an Academic Institution. (2023). Sorensen, Sabrina S ; Sethi, Sonali ; Hogarth, D K ; Kurman, Jonathan S ; Kristensen, Anders E. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:7:y:2023:i:4:d:10.1007_s41669-023-00417-y.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2022

YearCiting document
2022.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

Recent citations received in 2021

YearCiting document
2021Modelling the economic impact of reducing loneliness in community dwelling older people in england. (2021). A-La Park, ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:108594.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Per. (2021). Lopes, Gilberto ; Burke, Thomas ; Insinga, Ralph ; Qiao, Nan. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:4:d:10.1007_s41669-021-00288-1.

Full description at Econpapers || Download paper

Recent citations received in 2020

YearCiting document
2020.

Full description at Econpapers || Download paper

2020Impact of a Global Pandemic on Health Technology Assessment. (2020). Lorgelly, Paula ; Adler, Amanda. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-020-00590-9.

Full description at Econpapers || Download paper